Is Haleos Labs Limited debt-free?

Yes, Haleos Labs Limited is debt-free with a debt-to-equity ratio of 0.41.

Home

Haleos Labs Limited

Haleos Labs Limited Financials

Haleos Labs Limited Financial Statement

Haleos Labs Limited Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2025	Jun 2025	Mar 2025
Revenue	78.28	80.05	87.63
Operating Expense	67.04	68.21	79.83
Net Profit	4.98	5.16	2.68
Net Profit Margin	6.36	6.45	3.06
Earning Per Share	16.46	17.06	8.85
EBIDTA	11.17	11.77	8.14
Effective Tax Rate	17.79	18.99	12.82

Particulars	Sep 2025
Revenue	78.28
Operating Expense	67.04
Net Profit	4.98
Net Profit Margin	6.36
Earning Per Share	16.46
EBIDTA	11.17
Effective Tax Rate	17.79

Haleos Labs Limited Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	333.37	300.00	315.24
Operating Expenses Annual	289.14	265.57	288.84
Operating Profit Annual	48.18	38.27	31.64
Interest Annual	7.88	8.90	5.09
Depreciation	9.59	9.56	7.53
Net Profit Annual	21.37	13.07	13.22
Tax Annual	8.67	6.05	5.15

Particulars	Mar 2025
Total Revenue Annual	333.37
Operating Expenses Annual	289.14
Operating Profit Annual	48.18
Interest Annual	7.88
Depreciation	9.59
Net Profit Annual	21.37
Tax Annual	8.67

Haleos Labs Limited Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	0.33	0.15	0.95
Cash Flow from Operations	28.03	14.75	4.58
Cash Flow from Investing	-13.77	-13.75	-27.96
Cash Flow from Financing	-14.20	-0.82	22.59
Cash Flow at the End	0.40	0.33	0.15

Particulars	Mar 2025
Cash Flow at the Beginning	0.33
Cash Flow from Operations	28.03
Cash Flow from Investing	-13.77
Cash Flow from Financing	-14.20
Cash Flow at the End	0.40

Haleos Labs Limited Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	13.10	11.67	8.25
PBIT Margin (%)	10.31	8.56	5.93
PBT Margin (%)	9.01	7.61	4.78
Net PROFIT Margin (%)	5.80	3.98	3.76
Return On Networth / Equity (%)	11.45	7.68	7.20
Return On Networth /Employed (%)	13.69	10.68	8.85
Return On Assets (%)	7.72	4.97	5.60
Total Debt / Equity (X)	0.46	0.53	0.47
Asset Turnover Ratio (%)	1.33	1.25	1.49

Particulars	Mar 2025
PBDIT Margin (%)	13.10
PBIT Margin (%)	10.31
PBT Margin (%)	9.01
Net PROFIT Margin (%)	5.80
Return On Networth / Equity (%)	11.45
Return On Networth /Employed (%)	13.69
Return On Assets (%)	7.72
Total Debt / Equity (X)	0.46
Asset Turnover Ratio (%)	1.33

Haleos Labs Limited Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	150.23	138.23	139.61
Total Current Assets Annual	177.79	175.35	167.59
Non Current Assets Annual	180.52	172.88	169.80
Total Shareholders Funds Annual	197.18	176.23	164.03
Total Assets Annual	358.31	348.24	337.39

Particulars	Mar 2025
Fixed Assets Annual	150.23
Total Current Assets Annual	177.79
Non Current Assets Annual	180.52
Total Shareholders Funds Annual	197.18
Total Assets Annual	358.31

Haleos Labs Limited Earning Calls

EPS (INR)

Expected

20.20

Reported

20.19

Surprise

-0.05%

Jun 2025

EPS beaten by -0.05%

Mar 2025

EPS beaten by -0.15%

Dec 2024

EPS beaten by 0.00%

Dividend Pages

PE Ratio

FAQS on Haleos Labs Limited Financials

As of Dec 25, 2025, Haleos Labs Limited has a market capitalization of 326.64 Cr. Value Research classifies it as a Small-Cap company.

Yes, Haleos Labs Limited is with a debt-to-equity ratio of 0.41.

In FY 2024 , Haleos Labs Limited recorded a total revenue of approximately 333.37 Cr marking a significant milestone in the company's financial performance.

Haleos Labs Limited's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.0% annually, respectively..

Haleos Labs Limited's current PE ratio is 15.28.

Haleos Labs Limited's ROCE averaged 10.8% from the FY ending March 2023 to 2025, with a median of 10.5%. It peaked at 13.6% in March 2025, reflecting strong capital efficiency over the period..

Haleos Labs Limited's latest EBIT is Rs. 37.92 Cr, surpassing the average EBIT of Rs. 29.80 Cr over the 5 years..